Evidence map›Paper›PMID 38075637›Full record

ArticleTechnical innovations & patient support in radiation oncology2023

Multimodal treatment with chemoradiotherapy, regional hyperthermia and interstitial brachytherapy for a huge locally advanced cervical cancer: A case report.

Takashi Saito, Motohiro Murakami, Taisuke Sumiya, Daisuke Kobayashi, Haruka Shirataki, Den Fujioka, Keiichiro Baba, Hiroya Itagaki, Yuri Tenjimbayashi, Toyomi Satoh and 1 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Technical innovations & patient support in radiation oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 70% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 0 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Takashi SaitoDepartment of Radiation Oncology, University of Tsukuba, Tsukuba, Japan.
Motohiro MurakamiDepartment of Radiation Oncology, University of Tsukuba, Tsukuba, Japan.
Taisuke SumiyaDepartment of Radiation Oncology, University of Tsukuba, Tsukuba, Japan.
Daisuke KobayashiDepartment of Radiology, University of Tsukuba Hospital, Tsukuba, Japan.
Haruka ShiratakiDepartment of Radiation Oncology, University of Tsukuba, Tsukuba, Japan.
Den FujiokaDepartment of Radiation Oncology, University of Tsukuba, Tsukuba, Japan.
Keiichiro BabaDepartment of Radiation Oncology, University of Tsukuba, Tsukuba, Japan.
Hiroya ItagakiDepartment of Obstetrics and Gynecology, University of Tsukuba, Tsukuba, Japan.
Yuri TenjimbayashiDepartment of Obstetrics and Gynecology, University of Tsukuba, Tsukuba, Japan.
Toyomi SatohDepartment of Obstetrics and Gynecology, University of Tsukuba, Tsukuba, Japan.
Hideyuki SakuraiDepartment of Radiation Oncology, University of Tsukuba, Tsukuba, Japan.
University of Tsukuba · JPUniversity of Tsukuba Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A female patient in her 50 s was found to have a 10-cm tumor resulting from locally advanced cervical cancer (LACC). Three-year relapse-free survival was achieved following a multimodal treatment strategy integrating chemoradiotherapy (CRT), regional hyperthermia (RHT), and interstitial brachytherapy (ISBT). Given the large size of the tumor, enhancement of the geometrical dose distribution was anticipated using ISBT. However, delivery of a sufficient dose to the high-risk clinical target volume was predicted to be challenging. Thus, RHT was incorporated to potentially augment the overall treatment effect. This unique combination of CRT, RHT and ISBT may be promising for management of large LACC and warrants further investigation.

Indexed as

BrachytherapyCervical cancerChemoradiotherapyHyperthermiaMultimodal treatment

Identifiers

PMID38075637
PMCPMC10700532
OpenAlexW4388798027

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.